HSA — authorised 12 April 2000
- Marketing authorisation holder: VALEANT LUXEMBOURG
- Status: likely_approved
HSA authorised Visudyne on 12 April 2000
Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.
Yes. HSA authorised it on 12 April 2000.
VALEANT LUXEMBOURG holds the Singaporean marketing authorisation.